Hepatitis B edible vaccine - Boyce Thompson Institute for Plant Research
Latest Information Update: 19 Jan 2007
At a glance
- Originator Boyce Thompson Institute for Plant Research
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 21 Nov 2000 The Boyce Thompson Institute is seeking a corporate partner for continued development of the edible hepatitis B vaccine (http://bti.cornell.edu/)
- 05 Jul 2000 The assets and technology of Axis Genetics have been sold to Dow AgroSciences
- 10 Sep 1999 Axis Genetics has been placed into administration and a buyer is being sought for its business and assets